Nelson Menezes Vascular Spclst - 11201 Brooklyn, NY

Business Name: Nelson Menezes Vascular Spclst
Categorized In: Doctors
Address: 186 Joralemon St # 1002, Brooklyn, NY 11201
Phone Number: (718) 625-4100
Contact Person: G Moore, Office Manager
Website Address: brooklynveindoc.com
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $1.000.000 to $2.499.999
Share This Business:
Similar Businesses: Danielle Geraldi-Samara MD - Brooklyn, NY 11201
Mittman Neil MD - Brooklyn, NY 11201
Yim Victor Joe MD - Brooklyn, NY 11201
Kumbar Lalathaksha MD - Brooklyn, NY 11201
Fein Paul A MD - Brooklyn, NY 11201
Mamun Ali Asa MD - Brooklyn, NY 11201
Locke Rebecca J MD - Brooklyn, NY 11201
Milo F. Vassallo, MD, PhD - Brooklyn, NY 11201
University Ophthalmic Conslnt - Brooklyn, NY 11201
Marks Carole M MD - Brooklyn, NY 11201
Mpj - Brooklyn, NY 11201
Rafiaa Amer MD - Brooklyn, NY 11201
Lawrence Brown Dr - Brooklyn, NY 11201
Brooklyn Dermatology - Brooklyn, NY 11201
Lim Jessica W MD - Brooklyn, NY 11201
Monsanto E H MD - Brooklyn, NY 11201
Schwartz Jerome S MD - Brooklyn, NY 11201
Gerolemou Adela R MD - Brooklyn, NY 11201
Di Pillo Frank MD - Brooklyn, NY 11201
Smith Alyson W MD - Brooklyn, NY 11201

Nelson Menezes Vascular Spclst provides professional Doctors from its single location at the coordinates 40.692614,-73.991816.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $1.000.000 to $2.499.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 186 Joralemon St # 1002, Brooklyn, New York 11201 or contacted through representative G Moore, Office Manager at (718) 625-4100.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Nelson Menezes Vascular Spclst through its company website at brooklynveindoc.com. Engage with this business on its social media platforms through on Twitter and on Facebook.